ADARING

Brand name authorized in: Poland

Active ingredients

The drug ADARING contains a combination of these active pharmaceutical ingredients (APIs):

1 Etonogestrel
UNII 304GTH6RNH - ETONOGESTREL

Etonogestrel is the biologically active metabolite of desogestrel, a progestagen widely used in OCs. It is structurally derived from 19-nortestosterone and binds with high affinity to progesterone receptors in the target organs. The contraceptive effect of etonogestrel is primarily achieved by inhibition of ovulation.

Read about Etonogestrel
2 17 alpha-Ethinylestradiol
UNII 423D2T571U - ETHINYL ESTRADIOL

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.

Read about 17 alpha-Ethinylestradiol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Vaginal ring with progestogen and estrogen
G Genito urinary system and sex hormones → G02 Other gynecologicals → G02B Contraceptives for topical use → G02BB Intravaginal contraceptives
Discover more medicines within G02BB01